Ddev Plastiks has scheduled its FY26 earnings call for the 26th of May, 2026. Investors can expect updates on both Q4 and full-year financial performance, which will be shared online.

Large block trade of 805,483 Apollo Tyres shares worth approximately INR 31.72 crore changes hands at INR 393.8 each on the NSE.

RVNL saw a significant 59% decrease in Q4 net profit, reporting at ₹187 crores. On the other hand, BEL secured new orders worth ₹608 crores. Paytm is planning to invest $9 million in Paytm Europe, while ABFRL's losses in Q4 have increased, reaching ₹148.4 crores.

NTPC adjusts the repayment dates for Series 61 bonds to May 27, 2026, due to changes in Id-ul-Zuha holidays. The revised payment applies to ISINs INE733E07KC2 and INE733E07KD0.

Analysts suggest investing in HDFC Bank, Wockhardt, ACME Solar, Titagarh Rail, and Bajaj Finance for potential growth. Predicted price targets are Rs 796 for HDFC Bank, Rs 870 for Titagarh Rail, Rs 320 for ACME Solar, Rs 1,700 for Wockhardt, and Rs 970 for Bajaj Finance.

Uniparts India has announced its financial results for FY26, with a clean auditor's opinion. Notable points include an exceptional gain of approximately ₹28.1 million due to labor code changes and a ₹30 million insurance claim following a fire at their Ludhiana plant.

Ruchi Infra's board meeting on the 28th of May will discuss and approve their FY26 results and amalgamation plan. The trading window for insiders will be closed from the 1st of April to the 30th of May, as per SEBI regulations.

VA Tech Wabag intends to boost its order book to triple its revenue, currently standing at more than four times, demonstrating ambitious growth plans. Additionally, the company is targeting a rise in their Operations and Maintenance (O&M) contribution from the current 17% up to 20%, indicating an emphasis on service expansion.

Eicher Motors soars after positive management updates, approaching a record high on the BSE. Torrent Pharma gains post robust results. Sterlite Tech rises due to specific news, while Divi's Lab weakens. The BSE approaches a lifetime high, with GAIL trending as well.

Minda Corporation's Q4 profit experienced a significant increase of 138%, reaching ₹124 crore, primarily driven by robust demand. This growth was also reflected in the company's revenue, which rose by 29% year-on-year to ₹1,704 crore, largely due to an uptick in electronics and vehicle premiumization.

Hindalco predicts that aluminum prices could reach $3,500 per ton by 2026 due to supply constraints. In response, the company plans to invest approximately INR 120 billion in India and aims to boost Novelis' EBITDA to $500 per ton.

Honasa Consumer's Q4 profits experienced a significant increase of 178% year-over-year, reaching INR 69.4 crore. Compared to the previous quarter, net profit grew by 38.2%.

Bacha Goutham sold approximately 268,000 shares of SKM Egg Products Export at an average price of ₹190.95 on the National Stock Exchange.

Ind-Swift Labs will disclose their Q4 and FY26 financial results during a board meeting scheduled for May 28, 2026. Details about the trading window closure have already been announced and can be found on their official website.

Welspun Corp's Q4 profits took a hit due to increased expenses, delayed project completions, and operational changes, despite maintaining robust order levels.

Kotak Mahindra Bank's Open Interest increased by 12.2%, suggesting heightened market interest in the bank, while its stock climbed 0.75% on May 22, 2026, amidst volatile market conditions and investor engagement.

Prestige Estates has shared their Q4 FY2026 performance highlights in an online investor presentation. This comprehensive report offers a breakdown of the company's financial results and overall performance, designed to keep shareholders informed.

Sun Pharma's U.S. formulation sales have experienced a 1.1% year-on-year decline, reaching $459 million in the recent report.

Allcargo Terminals has endorsed its financial results for the fiscal year 2026, with no changes to the auditor's assessment. The company has also appointed a new non-executive director and restructured its board, while acquiring a 25% stake in Allcargo Group Services Private Limited.

GAIL's Q4 results fell short, causing a dip in share prices. However, analysts at CLSA remain optimistic, predicting an 18% potential increase for the company.

Experts advise maintaining positions in Hitachi Energy and Aditya Birla Capital but suggest setting stop-loss levels at around Rs 32,000 and Rs 335 respectively. On the other hand, they recommend selling off JK Tyre, PNB, and GAIL due to their unfavorable outlooks. Maruti Suzuki should be approached with caution; investors may want to average their positions near Rs 11,000.

Elara Capital has revised its target price for RITES from ₹310 to ₹285, while maintaining a 'Buy' rating. The lowered target suggests a slight adjustment in the expected performance of the company.

SP Apparels' rating has been lowered from 'Good' to 'Average' by MarketsMojo due to a mix of factors such as inconsistent growth, high debt levels, and less impressive returns on equity and capital.

Experts advise maintaining positions in Hitachi Energy and Aditya Birla Capital but suggest setting stop-loss levels at around Rs 32,000 and Rs 335 respectively. On the other hand, they recommend selling off JK Tyre, PNB, and GAIL due to their unfavorable outlooks. Maruti Suzuki should be approached with caution; investors may want to average their positions near Rs 11,000.

The Competition Commission of India (CCI) has finally settled a decade-long antitrust case implicating 12 hospitals, including Max Healthcare. Max Healthcare officially confirmed the resolution of competition-related charges leveled against them by CCI.

ixigo's Q4 profit surged 91% YoY to INR 32 crores, and total revenue hit INR 308 crores. For the entire FY26, the company reported INR 1,228 crore in revenue, with flight-related GTV accounting for a significant portion at INR 2,018 crores.

CRISIL has given IIFL Capital a 'AA' rating for a loan of INR 175 crore with a positive outlook. Additionally, the ratings agency has maintained its 'A1' rating for short-term loans and commercial paper amounting to INR 2025 crore and INR 3050 crore respectively.

Anticipation builds for Aurobindo Pharma's Q4 results, with analysts sharing their views on the earnings via #AwaazEarnings. Stay tuned for updates on the company's performance.

Indian oil imports dropped significantly in April 2026, largely due to decreased purchases from Russia by Reliance Industries Limited (RIL) and Nayara Energy. This reverses a trend of high Russian oil imports seen in the previous month.

Electronics manufacturing giants Dixon, Kaynes, Amber Enterprises, and Syrma are under the spotlight for Q4 FY26, as highlighted by Snehi Shah's analysis on ET NOW, identifying emerging trends in India's electronics sector.

The Nifty Pharma index has significantly outperformed the broader market, increasing by 11% over the past month while the Nifty 50 experienced a decline of 3.6%. Notable standouts in this sector include Gland Pharma with a impressive 27% gain, Laurus Labs at 23%, and Biocon showing a 21% rise.

Wheels India reached a new peak at Rs 1,669.7 today, marking an impressive 8.1% increase in its share price. This growth indicates a continued robust performance for the auto component company.

Mankind Pharma has been upgraded to a 'Buy' rating by MarketsMojo, reflecting its strong fundamental improvements. This positive change is based on the company's impressive growth trajectory.

Bosch shares receive a final dividend of INR 270 per share, as announced by the company. Investors stand to gain significantly from this payout.

Hindalco shares could respond to Novelis' optimistic forecast, but lingering concerns over Hindalco's own performance might impact the reaction.

L7 Hitech has acquired a significant stake in Marsons Limited, purchasing 20,000 shares at approximately $2.03 per share. This move suggests potential interest or investment in Marsons' future growth.

ICRA Analytics, a financial research firm, has been issued a tax demand of approximately INR 19.2 crores for the upcoming fiscal year. Although this demand won't have an immediate impact on their finances, they plan to file an appeal in accordance with regulatory standards.

Strides Pharma has received approval from the National Company Law Tribunal (NCLT) to spin off Arcus Labs, creating a new entity, Pivot Path, focused on life sciences and digital innovation. Strides will maintain full ownership of Pivot Path, positioning itself for further growth in these areas.

SPARC and their partner, Ocuvex Therapeutics, have encountered a regulatory challenge in the U.S., with the FDA issuing a Complete Response Letter (CRL) regarding their application for PDP-716. This means that further discussions are needed between the companies and the FDA before approval can be granted in the American market.

Balaji Amines has commenced commercial manufacturing of Dimethyl Ether at its Unit-IV in Solapur, marking a significant expansion to their product line. This move is expected to boost the company's production capabilities and overall growth potential.